Taylor Lyons

538 total citations
13 papers, 331 citations indexed

About

Taylor Lyons is a scholar working on Clinical Psychology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Taylor Lyons has authored 13 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Psychology, 7 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Taylor Lyons's work include Psychedelics and Drug Studies (12 papers), Chemical synthesis and alkaloids (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Taylor Lyons is often cited by papers focused on Psychedelics and Drug Studies (12 papers), Chemical synthesis and alkaloids (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Taylor Lyons collaborates with scholars based in United Kingdom, United States and Germany. Taylor Lyons's co-authors include Robin Carhart‐Harris, Robin Carhart‐Harris, Thomas Knöpfel, Christopher Timmermann, Fernando E. Rosas, Leor Roseman, Hannes Kettner, Lea J. Mertens, Patrick L. McGeer and David Spanswick and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Taylor Lyons

11 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taylor Lyons United Kingdom 7 272 145 124 46 25 13 331
Joseph P. Barsuglia United States 14 424 1.6× 215 1.5× 205 1.7× 50 1.1× 53 2.1× 18 570
Robin von Rotz Switzerland 10 282 1.0× 204 1.4× 184 1.5× 28 0.6× 41 1.6× 17 427
Sophia Armand Denmark 10 204 0.8× 115 0.8× 115 0.9× 19 0.4× 25 1.0× 21 331
Luke T. J. Williams United Kingdom 5 336 1.2× 194 1.3× 166 1.3× 79 1.7× 12 0.5× 6 395
Meghan Hibicke United States 6 273 1.0× 172 1.2× 214 1.7× 28 0.6× 44 1.8× 13 341
Anna Forsyth New Zealand 12 288 1.1× 174 1.2× 141 1.1× 27 0.6× 98 3.9× 27 502
Jordan Sloshower United States 8 301 1.1× 208 1.4× 124 1.0× 26 0.6× 27 1.1× 10 348
Michael P. Bremmer United States 6 251 0.9× 155 1.1× 143 1.2× 54 1.2× 35 1.4× 9 341
Neiloufar Family United Kingdom 8 329 1.2× 200 1.4× 148 1.2× 82 1.8× 10 0.4× 15 406
Aaron Klaiber Switzerland 9 364 1.3× 257 1.8× 191 1.5× 51 1.1× 29 1.2× 15 392

Countries citing papers authored by Taylor Lyons

Since Specialization
Citations

This map shows the geographic impact of Taylor Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taylor Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taylor Lyons more than expected).

Fields of papers citing papers by Taylor Lyons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taylor Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taylor Lyons. The network helps show where Taylor Lyons may publish in the future.

Co-authorship network of co-authors of Taylor Lyons

This figure shows the co-authorship network connecting the top 25 collaborators of Taylor Lyons. A scholar is included among the top collaborators of Taylor Lyons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taylor Lyons. Taylor Lyons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Giribaldi, Bruna, et al.. (2025). The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial. European Neuropsychopharmacology. 97. 51–60. 1 indexed citations
2.
Kettner, Hannes, Leor Roseman, Meg J. Spriggs, et al.. (2025). Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies. Frontiers in Psychology. 16. 1580663–1580663.
3.
Zeifman, Richard J., Meg J. Spriggs, Hannes Kettner, et al.. (2025). From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS). Scientific Reports. 15(1). 3651–3651. 5 indexed citations
4.
Haijen, Eline, et al.. (2024). Validation of the imperial psychedelic predictor scale. Psychological Medicine. 54(12). 3539–3547.
5.
Weiss, Brandon, et al.. (2024). An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers. SHILAP Revista de lepidopterología. 4. 104092–104092. 1 indexed citations
6.
Lyons, Taylor, et al.. (2023). Cortical Correlates of Psychedelic-Induced Shaking Behavior Revealed by Voltage Imaging. International Journal of Molecular Sciences. 24(11). 9463–9463. 3 indexed citations
7.
Spriggs, Meg J., Bruna Giribaldi, Taylor Lyons, et al.. (2022). Body mass index (BMI) does not predict responses to psilocybin. Journal of Psychopharmacology. 37(1). 107–116. 12 indexed citations
8.
Kettner, Hannes, Lea J. Mertens, Leor Roseman, et al.. (2022). Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology. 36(1). 31–45. 77 indexed citations
9.
Lyons, Taylor, et al.. (2020). The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner. Journal of Psychopharmacology. 34(7). 786–794. 9 indexed citations
10.
Lyons, Taylor, et al.. (2018). Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice. Frontiers in Pharmacology. 9. 17–17. 38 indexed citations
11.
Lyons, Taylor & Robin Carhart‐Harris. (2018). More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression. Frontiers in Psychology. 9. 1721–1721. 42 indexed citations
12.
Lyons, Taylor & Robin Carhart‐Harris. (2018). Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. Journal of Psychopharmacology. 32(7). 811–819. 113 indexed citations
13.
O‘Hare, Eugene, Ross Jeggo, Eun‐Mee Kim, et al.. (2015). Lack of support for bexarotene as a treatment for Alzheimer's disease. Neuropharmacology. 100. 124–130. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026